Last reviewed · How we verify

Acetylsalicylzuur Apotex Cardio

AstraZeneca · Phase 1 active Small molecule

Acetylsalicylzuur Apotex Cardio is a NSAID Small molecule drug developed by AstraZeneca. It is currently in Phase 1 development for Cardiovascular disease prevention, Antiplatelet therapy.

Inhibits COX-1 and COX-2 enzymes

Inhibits COX-1 and COX-2 enzymes Used for Cardiovascular disease prevention, Antiplatelet therapy.

At a glance

Generic nameAcetylsalicylzuur Apotex Cardio
SponsorAstraZeneca
Drug classNSAID
TargetCOX-1 and COX-2
ModalitySmall molecule
Therapeutic areaCardiovascular
PhasePhase 1

Mechanism of action

Acetylsalicylic acid is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting the production of prostaglandins through the inhibition of cyclooxygenase enzymes (COX-1 and COX-2).

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Acetylsalicylzuur Apotex Cardio

What is Acetylsalicylzuur Apotex Cardio?

Acetylsalicylzuur Apotex Cardio is a NSAID drug developed by AstraZeneca, indicated for Cardiovascular disease prevention, Antiplatelet therapy.

How does Acetylsalicylzuur Apotex Cardio work?

Inhibits COX-1 and COX-2 enzymes

What is Acetylsalicylzuur Apotex Cardio used for?

Acetylsalicylzuur Apotex Cardio is indicated for Cardiovascular disease prevention, Antiplatelet therapy.

Who makes Acetylsalicylzuur Apotex Cardio?

Acetylsalicylzuur Apotex Cardio is developed by AstraZeneca (see full AstraZeneca pipeline at /company/astrazeneca).

What drug class is Acetylsalicylzuur Apotex Cardio in?

Acetylsalicylzuur Apotex Cardio belongs to the NSAID class. See all NSAID drugs at /class/nsaid.

What development phase is Acetylsalicylzuur Apotex Cardio in?

Acetylsalicylzuur Apotex Cardio is in Phase 1.

What are the side effects of Acetylsalicylzuur Apotex Cardio?

Common side effects of Acetylsalicylzuur Apotex Cardio include Gastrointestinal upset, Hypersensitivity reactions, Renal impairment.

What does Acetylsalicylzuur Apotex Cardio target?

Acetylsalicylzuur Apotex Cardio targets COX-1 and COX-2 and is a NSAID.

Related